GetTopicDetailResponse(id=e6f71244e794, topicName=CD3xCD20, introduction=, content=靶向免疫療法 CD3xCD20, image=null, comments=0, allHits=236, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Feb 21 14:37:47 CST 2025, time=2025-02-21, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501770, tagList=[TagDto(tagId=501770, tagName=CD3xCD20)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2270414, encodeId=1d3f22e041471, content=<a href='/topic/show?id=2ad83e51258' target=_blank style='color:#2F92EE;'>#雙特異性抗體#</a> <a href='/topic/show?id=e6f71244e794' target=_blank style='color:#2F92EE;'>#CD3xCD20#</a>, objectTitle=【CII】中山大學(xué)腫瘤防治中心牽頭開發(fā)預(yù)測(cè)CD3xCD20雙抗CRS風(fēng)險(xiǎn)的列線圖, objectType=article, longId=883692, objectId=f560883692d8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659342224826_8252897.webp, objectUrl=/article/show_article.do?id=f560883692d8, replyNumber=0, likeNumber=24, createdTime=2025-06-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f560883692d8, moduleTitle=【CII】中山大學(xué)腫瘤防治中心牽頭開發(fā)預(yù)測(cè)CD3xCD20雙抗CRS風(fēng)險(xiǎn)的列線圖, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f560883692d8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2252971, encodeId=c47d22529e18a, content=<a href='/topic/show?id=a45c1244e682' target=_blank style='color:#2F92EE;'>#靶向免疫療法#</a> <a href='/topic/show?id=e6f71244e794' target=_blank style='color:#2F92EE;'>#CD3xCD20#</a>, objectTitle=?CD3×CD20雙抗治療淋巴瘤的預(yù)后標(biāo)志物, objectType=article, longId=864155, objectId=ae8b8641556a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250211/1739237818333_8538692.png, objectUrl=/article/show_article.do?id=ae8b8641556a, replyNumber=0, likeNumber=26, createdTime=2025-02-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=ae8b8641556a, moduleTitle=?CD3×CD20雙抗治療淋巴瘤的預(yù)后標(biāo)志物, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ae8b8641556a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-21發(fā)表于陜西省
